TD Asset Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.43M | Sell |
116,332
-53,600
| -32% | -$2.96M | 0.01% | 732 |
|
|
2025
Q1 | $8.22M | Sell |
169,932
-3,770
| -2% | -$182K | 0.01% | 688 |
|
|
2024
Q4 | $6.7M | Buy |
173,702
+1,500
| +0.9% | +$57.9K | 0.01% | 731 |
|
|
2024
Q3 | $7.67M | Buy |
172,202
+23,900
| +16% | +$1.06M | 0.01% | 693 |
|
|
2024
Q2 | $5.14M | Buy |
148,302
+39,850
| +37% | +$1.38M | ﹤0.01% | 760 |
|
|
2024
Q1 | $3.14M | Sell |
108,452
-2,348
| -2% | -$67.9K | ﹤0.01% | 892 |
|
|
2023
Q4 | $2.54M | Hold |
110,800
| – | – | ﹤0.01% | 929 |
|
|
2023
Q3 | $1.85M | Buy |
110,800
+55,400
| +100% | +$924K | ﹤0.01% | 979 |
|
|
2023
Q2 | $1.53M | Buy |
55,400
+26,400
| +91% | +$729K | ﹤0.01% | 1026 |
|
|
2023
Q1 | $667K | Buy |
+29,000
| New | +$667K | ﹤0.01% | 1215 |
|
|
2022
Q2 | – | Sell |
-17,842
| Closed | -$422K | – | 1505 |
|
|
2022
Q1 | $422K | Sell |
17,842
-15,200
| -46% | -$360K | ﹤0.01% | 1358 |
|
|
2021
Q4 | $1.13M | Sell |
33,042
-14,000
| -30% | -$479K | ﹤0.01% | 1256 |
|
|
2021
Q3 | $834K | Sell |
47,042
-21,800
| -32% | -$386K | ﹤0.01% | 1298 |
|
|
2021
Q2 | $3.4M | Buy |
68,842
+7,371
| +12% | +$364K | ﹤0.01% | 932 |
|
|
2021
Q1 | $1.59M | Buy |
61,471
+10,219
| +20% | +$265K | ﹤0.01% | 1158 |
|
|
2020
Q4 | $1.03M | Buy |
51,252
+11,899
| +30% | +$240K | ﹤0.01% | 1178 |
|
|
2020
Q3 | $769K | Hold |
39,353
| – | – | ﹤0.01% | 1138 |
|
|
2020
Q2 | $695K | Buy |
+39,353
| New | +$695K | ﹤0.01% | 1147 |
|